Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aratana Theraptcs (PETX)

Aratana Theraptcs (PETX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
JDRF T1D Fund Appoints Veteran Life Sciences Executive Dr. Steven St. Peter as Managing Director

The JDRF T1D Fund, the venture philanthropy fund focused on accelerating life-changing solutions to cure, prevent, and treat type 1 diabetes (T1D) through catalytic investments, today announced the expansion...

PETX : 4.92 (-0.20%)
RYTM : 19.08 (-0.93%)
SNDX : 8.50 (-1.73%)
PRTO : 0.84 (+28.45%)
iOmx Therapeutics Strengthens Executive Management Team and Supervisory Board

iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on novel immune checkpoint targets, today announced significant changes to the company's executive management...

PETX : 4.92 (-0.20%)
Elanco Finalizes Acquisition of Aratana Therapeutics

Elanco Animal Health Incorporated (NYSE: ELAN), today finalized the acquisition of Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing and commercializing innovative therapeutics...

ELAN : 31.23 (+1.99%)
PETX : 4.92 (-0.20%)
Aratana Therapeutics' Stockholders Adopt Merger Agreement with Elanco Animal Health

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting results for...

PETX : 4.92 (-0.20%)
Rigrodsky & Long, P.A. Files Class Action Suit Against Aratana Therapeutics, Inc.

Rigrodsky & Long, P.A.:

PETX : 4.92 (-0.20%)
Aratana Therapeutics Reports Voting Results from 2019 Annual Meeting of Stockholders

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting results for...

PETX : 4.92 (-0.20%)
AMBR, PETX Shareholder Class Actions: Halper Sadeh LLP Announces Shareholder Class Action Lawsuits Against Amber Road, Inc. and Aratana Therapeutics, Inc. - AMBR, PETX

Halper Sadeh LLP, a global investor rights law firm, announces the filing of class action lawsuits against Amber Road, Inc. (NYSE: AMBR) and Aratana Therapeutics, Inc. (NASDAQ: PETX). The lawsuits seek...

AMBR : 13.05 (-0.08%)
PETX : 4.92 (-0.20%)
Rigrodsky & Long, P.A. Files Class Action Suit Against Aratana Therapeutics, Inc.

Rigrodsky & Long, P.A.:

PETX : 4.92 (-0.20%)
PETX, ADSW, AQ Shareholder Alert: Halper Sadeh LLP Reminds Investors of Class Action Lawsuits Filed Against Aratana Therapeutics, Inc., Advanced Disposal Services, Inc., and Aquantia Corp. - PETX, ADSW, AQ

Halper Sadeh LLP, a global investor rights law firm, announces that class action lawsuits were filed against Aratana Therapeutics, Inc. (NASDAQ: PETX), Advanced Disposal Services, Inc. (NYSE: ADSW), and...

PETX : 4.92 (-0.20%)
ADSW : 32.95 (+0.06%)
AQ : 13.24 (unch)
Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., Community Health Systems, Equity Bancshares, Inc., Ford Motor Company, Interface, Inc., Monotype Imaging Holdings, Inc., PetIQ, Inc., and Pinduoduo, Inc.

Aratana Therapeutics, Inc. (PETX)

PETX : 4.92 (-0.20%)
CYH : 3.93 (+1.03%)
EQBK : 27.76 (-0.43%)
F : 9.20 (-0.11%)
TILE : 16.13 (+0.50%)
TYPE : 19.84 (+0.05%)
PETQ : 29.75 (+0.92%)
PDD : 39.08 (-0.66%)
PETX, KEYW, and ZAYO SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

Rigrodsky & Long, P.A. announces that it is investigating:

PETX : 4.92 (-0.20%)
KEYW : 11.23 (-0.18%)
JEC : 85.84 (+0.96%)
ZAYO : 34.77 (-0.03%)
Aratana (PETX) Reports Q1 Loss, Tops Revenue Estimates

Aratana (PETX) delivered earnings and revenue surprises of -40.00% and 5.51%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

PETX : 4.92 (-0.20%)
Aratana: 1Q Earnings Snapshot

LEAWOOD, Kan. (AP) _ Aratana Therapeutics Inc. (PETX) on Wednesday reported a loss of $6.8 million in its first quarter.

PETX : 4.92 (-0.20%)
Aratana Therapeutics Reports First Quarter 2019 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, announced its first quarter 2019 financial...

PETX : 4.92 (-0.20%)
Aratana Therapeutics to Present at Stifel 2019 Dental & Veterinary Conference

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, plans on presenting at the Stifel Dental...

PETX : 4.92 (-0.20%)
INVESTOR ALERT: Monteverde & Associates PC is Investigating the Announced Buyout

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

PETX : 4.92 (-0.20%)
EFII : 36.97 (-0.03%)
ADSW : 32.95 (+0.06%)
APU : 31.22 (-2.28%)
APC : 72.77 (+0.78%)
GDI : 34.59 (+0.09%)
ARATANA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aratana Therapeutics - PETX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Aratana Therapeutics (NasdaqGM: PETX)...

PETX : 4.92 (-0.20%)
ELAN : 31.23 (+1.99%)
PETX, WP, and EFII SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

Rigrodsky & Long, P.A. announces that it is investigating:

PETX : 4.92 (-0.20%)
EFII : 36.97 (-0.03%)
WP : 135.00 (-2.07%)
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Aratana Therapeutics, Inc. (PETX) on Behalf of Stockholders and Encourages PETX Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Aratana Therapeutics, Inc. (NASDAQ: PETX) on behalf of stockholders concerning the proposed merger with Elanco...

PETX : 4.92 (-0.20%)
ELAN : 31.23 (+1.99%)
QTNA, PETX, SFS Shareholder Alert: Halper Sadeh LLP Reminds Investors it is Investigating Whether the Sale of These Companies is Fair to Shareholders - QTNA, PETX, SFS

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

QTNA : 24.51 (+1.07%)
PETX : 4.92 (-0.20%)
SFS : 6.50 (+0.15%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +1.53 , SEDG -0.67 , THC +0.18 , TER +1.78 , LITE +1.99
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar